All
the news

Filtre

4th Global Congress on Sickle Cell Disease

14/06/22

Join Biomaneo & Shimadzu at the 4th Global Congress on Sickle Cell Disease taking place in Paris from June 16-18. 

Biomaneo obtains ISO 13485:2016 certification and strengthens its quality team

31/08/21

A key step for the marketing of its In Vitro Diagnostic Devices (IVDD) and in the transition to the new 2017/746 regulation.

New NeoSickle installation

26/08/21

With this second installation, 80% of French samples are now analysed using the NeoSickle solution.

Biomaneo puts the spotlight on the training of young people...

23/10/20

By welcoming three new employees to its teams

Biomaneo obtains the "Label Initiative Remarquable"

21/09/20

We are pleased to announce that we have just joined the 1st community of impact entrepreneurs in France...

A new shareholder into our business

20/12/19

In Dijon, Biomaneo is collecting additional financial resources from BFC Croissance & Innovation to continue the development of screening...